Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Alpha-Lipoic Acid (ALA) has some scientific support for its use in supporting the hepatic (liver) system, particularly in the context of liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and drug-induced liver injury. ALA is a potent antioxidant that can scavenge free radicals and regenerate other antioxidants, such as vitamins C and E. Several animal and human studies suggest that ALA may reduce oxidative stress and inflammation in the liver, which are central mechanisms involved in various liver disorders.

Clinical trials have demonstrated that ALA supplementation can improve liver enzyme levels (such as ALT and AST) and reduce markers of oxidative stress in patients with NAFLD and other liver conditions. Some studies have also shown that ALA may help mitigate hepatotoxicity caused by toxins or medications, such as acetaminophen or chemotherapy drugs. However, while these findings are promising, the overall body of evidence is moderate, with some studies being small in size or of limited duration. Larger, high-quality randomized controlled trials are still needed to confirm efficacy, determine optimal dosing, and assess long-term safety.

In summary, there is reasonable scientific rationale and some clinical evidence supporting the use of Alpha-Lipoic Acid for liver support, but it should not replace established therapies for liver diseases. Its role is best seen as adjunctive, and patients should consult healthcare professionals before starting supplementation.

More about Alpha-Lipoic Acid
More about Hepatic System

Other ingredients that support Hepatic System

Other body systems supported by Alpha-Lipoic Acid

Products containing Alpha-Lipoic Acid